Send us a text This week on IPWatchdog Unleashed, we panel discussion that took place on October 27 as a part of our annual life sciences program. Initially styled as a conversation about how artificial intelligence is transforming life sciences, it becomes quickly apparent that the conversation was not going to be limited to the life sciences sector but instead was a robust discussion about what any innovative company should consider when considering the adoption of AI tools. Indeed, the dis...
All content for IPWatchdog Unleashed is the property of Gene Quinn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This week on IPWatchdog Unleashed, we panel discussion that took place on October 27 as a part of our annual life sciences program. Initially styled as a conversation about how artificial intelligence is transforming life sciences, it becomes quickly apparent that the conversation was not going to be limited to the life sciences sector but instead was a robust discussion about what any innovative company should consider when considering the adoption of AI tools. Indeed, the dis...
Dupes, Deception and Damage Control: Leveraging IP to Safeguard Brand Equity
IPWatchdog Unleashed
1 hour 1 minute
1 month ago
Dupes, Deception and Damage Control: Leveraging IP to Safeguard Brand Equity
Send us a text In this episode of IPWatchdog Unleashed, host Gene Quinn sits down with Gina Johnson, the Chief Legal Officer of Ridge Wallet, LLC. They dive into Ridge Wallet's approach to intellectual property, and how the company relies on design patents, utility patents, and trademarks to fully protect their products against fakes, dupes, counterfeits and knockoffs. Gina shares her transition from outside counsel to an in-house role, the strategic importance of IP in combating market confu...
IPWatchdog Unleashed
Send us a text This week on IPWatchdog Unleashed, we panel discussion that took place on October 27 as a part of our annual life sciences program. Initially styled as a conversation about how artificial intelligence is transforming life sciences, it becomes quickly apparent that the conversation was not going to be limited to the life sciences sector but instead was a robust discussion about what any innovative company should consider when considering the adoption of AI tools. Indeed, the dis...
